Literature DB >> 10930302

Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production.

C J Watson1, N J Webb, M J Bottomley, P E Brenchley.   

Abstract

Dysregulated vascular endothelial growth factor (VEGF) expression has been implicated as a major contributor to the development of a number of common disease pathologies. The aim of this study was to establish the extent of genetic variability within the VEGF gene and to determine whether this genetic variation influenced levels of VEGF protein expression. The promoter region and exon 1 of the VEGF gene were screened for polymorphisms using single-stranded conformation (SSCP) polymorphism analysis and direct PCR-sequencing. We identified 15 novel sequence polymorphisms most of which were rare. Eleven of these polymorphisms were single base substitutions, three were single base insertions and one was a two base deletion. Thirteen of the polymorphisms were located within the promoter and two in the 5' untranslated region (5'UTR) of the gene. We established PCR-RFLP typing systems for ten of the polymorphisms. For the two common polymorphisms at -460 and +405, we developed a combined sequence specific priming (SSP) PCR typing system to determine the cis/trans orientation of each allele and hence, ascertain haplotypes. A significant correlation was observed between lipopolysaccharide (LPS) stimulated peripheral blood mononuclear cell (PBMC) VEGF protein production and genotype for the +405 polymorphism. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930302     DOI: 10.1006/cyto.2000.0692

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  205 in total

Review 1.  Antagonising angiogenesis in rheumatoid arthritis.

Authors:  P E Brenchley
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

Review 2.  Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

Authors:  P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

3.  Meta analysis on the relationship between gene polymorphisms of vascular endothelial growth factor and retinal prognosis risk of prematurity.

Authors:  Jun Zhai; Qiu-Hui Jiang; Chun-Xi Liu; Zuo-Rong Tian; Ying-Pu Sun
Journal:  Int J Ophthalmol       Date:  2012-06-18       Impact factor: 1.779

4.  Role of five small nucleotide polymorphisms in the VEGF gene on the susceptibility to osteosarcoma and overall survival of patients.

Authors:  Jian-Qiang Liu; Xia Bai; DE-Chen Duan; Ai-Xia Dou
Journal:  Oncol Lett       Date:  2015-06-19       Impact factor: 2.967

5.  New models of lipopolysaccharide-induced implantation loss reveal insights into the inflammatory response.

Authors:  Sarah Moustafa; Dana N Joseph; Robert N Taylor; Shannon Whirledge
Journal:  Am J Reprod Immunol       Date:  2019-01-28       Impact factor: 3.886

6.  Promoter polymorphisms of the vascular endothelial growth factor gene are associated with metabolic syndrome susceptibility in Koreans.

Authors:  Young Ree Kim; Seung-Ho Hong
Journal:  Biomed Rep       Date:  2017-04-07

7.  VEGF-A and VEGFR1 SNPs associate with preeclampsia in a Philippine population.

Authors:  Melissa D Amosco; Van Anthony M Villar; Justin Michael A Naniong; Lara Marie G David-Bustamante; Pedro A Jose; Cynthia P Palmes-Saloma
Journal:  Clin Exp Hypertens       Date:  2016-09-26       Impact factor: 1.749

8.  Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.

Authors:  T Langsenlehner; E-M Thurner; W Renner; A Gerger; K S Kapp; U Langsenlehner
Journal:  Strahlenther Onkol       Date:  2014-01-18       Impact factor: 3.621

9.  Association of vascular endothelial growth factor C-634 g polymorphism in taiwanese children with Kawasaki disease.

Authors:  K-C Hsueh; Y-J Lin; J-S Chang; L Wan; Y-H Tsai; C-H Tsai; C-P Chen; F-J Tsai
Journal:  Pediatr Cardiol       Date:  2007-09-15       Impact factor: 1.655

10.  VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab.

Authors:  Anna Luisa Di Stefano; Marianne Labussiere; Giuseppe Lombardi; Marica Eoli; Donata Bianchessi; Francesco Pasqualetti; Patrizia Farina; Stefania Cuzzubbo; Jaime Gallego-Perez-Larraya; Blandine Boisselier; Francois Ducray; Caroline Cheneau; Arrigo Moglia; Gaetano Finocchiaro; Yannick Marie; Amithys Rahimian; Khe Hoang-Xuan; Jean Yves Delattre; Karima Mokhtari; Marc Sanson
Journal:  J Neurooncol       Date:  2014-12-07       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.